Kowalczyk Agnieszka, Krogulska Aneta
Department of Paediatrics, Allergology and Gastroenterology, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland.
Postepy Dermatol Alergol. 2024 Feb;41(1):56-65. doi: 10.5114/ada.2023.135676. Epub 2024 Feb 28.
Allergic rhinitis (AR) is the most common allergic disease in the world, and additionally, its prevalence is successively increasing. Children with AR constitute a heterogeneous group of patients differing both in the course of AR and in the frequency of asthma coexistence. It is possible to identify children with AR at risk of a more severe course of the disease by analysing the potential family, environmental and clinical factors related to the development of the disease; the findings will help identify patients with a higher risk of developing asthma in the future, and who will benefit the most from early allergen-specific immunotherapy.
Evaluation of clinical relevance of cluster analysis in phenotyping AR based on an analysis of selected clinical and environmental factors.
The study sample was 80 children (7-17 y.o.) with AR, including 28 children with associated asthma. The effects of AR symptoms on the patients daily functioning, skin prick tests (Allergopharma), allergen-specific IgE for airborne allergens (Biocheck GmbH), total cholesterol, cholesterol high-density lipoprotein (HDL), cholesterol low-density lipoprotein (LDL), triglyceride levels in the blood (ARCHITECTcSystem), FeNO and nNO concentrations (HypAir FeNO Medisoft) and results of methacholine challenge test (Lungtest 1000Ispa) were analysed.
Four clusters of patients with AR were extracted, differing in the incidence and severity of AR symptoms and the coincidence of asthma. Most of the children from cluster 1 ( = 24; 85.71%) and cluster 2 ( = 15; 78.95%) had persistent AR, while most of the children from cluster 3 ( = 11; 73.33%) and cluster 4 ( = 14; 77.78%) had intermittent AR. The co-occurrence of asthma was significantly higher in cluster 1 than in other clusters ( = 0.0002). Children in clusters 3 and 4 reported a lower impact of AR symptoms on daily functioning ( = 0.0153). Children in cluster 1 had significantly more often an abnormally high total cholesterol level ( = 0.033) and in cluster 4 significantly more often abnormally high triglyceride levels ( = 0.009) were observed. Patients in cluster 2 were significantly less likely to have abnormal high LDL levels ( = 0.015).
Children with AR from the Kuyavian-Pomeranian voivodeship differing in the course of AR, the frequency of coexistence of asthma, and occurrence of lipid parameter abnormalities.
变应性鼻炎(AR)是世界上最常见的变应性疾病,此外,其患病率还在持续上升。患有AR的儿童构成了一组异质性患者群体,他们在AR病程和哮喘共存频率方面存在差异。通过分析与该疾病发展相关的潜在家庭、环境和临床因素,有可能识别出患病情程更严重的AR儿童;这些发现将有助于识别未来患哮喘风险更高、且将从早期变应原特异性免疫治疗中获益最大的患者。
基于对选定临床和环境因素的分析,评估聚类分析在AR表型分析中的临床相关性。
研究样本为80名患有AR的儿童(7 - 17岁),其中包括28名伴有哮喘的儿童。分析了AR症状对患者日常功能的影响、皮肤点刺试验(Allergopharma)、空气中变应原的变应原特异性IgE(Biocheck GmbH)、总胆固醇、高密度脂蛋白胆固醇(HDL)、低密度脂蛋白胆固醇(LDL)、血液中甘油三酯水平(ARCHITECTcSystem)、呼出一氧化氮(FeNO)和鼻腔一氧化氮(nNO)浓度(HypAir FeNO Medisoft)以及乙酰甲胆碱激发试验结果(Lungtest 1000Ispa)。
提取出四组患有AR的患者,他们在AR症状的发生率和严重程度以及哮喘的并存情况方面存在差异。第1组(n = 24;85.71%)和第2组(n = 15;78.95%)的大多数儿童患有持续性AR,而第3组(n = 11;73.33%)和第4组(n = 14;77.78%)的大多数儿童患有间歇性AR。第1组中哮喘的共病率显著高于其他组(p = 0.0002)。第3组和第4组的儿童报告AR症状对日常功能的影响较低(p = 0.0153)。第1组儿童总胆固醇水平异常升高的情况显著更常见(p = 0.033),而在第4组中观察到甘油三酯水平异常升高的情况显著更常见(p = 0.009)。第2组患者LDL水平异常升高的可能性显著更低(p = 0.015)。
来自库亚维-波美拉尼亚省的患有AR的儿童在AR病程、哮喘共存频率和脂质参数异常发生情况方面存在差异。